Citius Pharmaceuticals
CTXR
CTXR
60 hedge funds and large institutions have $14M invested in Citius Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 11 increasing their positions, 18 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
48% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 29
68% less capital invested
Capital invested by funds: $43.2M → $14M (-$29.3M)
Holders
60
Holding in Top 10
–
Calls
$468K
Puts
$73K
Top Buyers
| 1 | +$1.6M | |
| 2 | +$416K | |
| 3 | +$314K | |
| 4 |
Morgan Stanley
New York
|
+$149K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$114K |
Top Sellers
| 1 | -$5.28M | |
| 2 | -$1.49M | |
| 3 | -$928K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$885K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$795K |